Cardiac arrhythmias in childhood. Diagnostic considerations and treatment
1Children's Memorial Hospital, Chicago, Illinois.
Insights
Safe antiarrhythmic therapy in children requires understanding arrhythmia mechanisms and risks. Treatment options for supraventricular tachycardia and ventricular tachycardia vary based on cardiac health, prioritizing efficacy and minimizing side effects.
Area of Science:
- Pediatric Cardiology
- Clinical Electrophysiology
- Pharmacology
Background:
- Determining safe and effective antiarrhythmic therapy in pediatric patients necessitates a thorough understanding of arrhythmia mechanisms and associated risk factors.
- Non-invasive evaluation modalities such as ECG, 24-hour Holter monitoring, and transtelephonic ECG transmission are crucial for diagnosis.
Purpose of the Study:
- To outline the principles and modalities for managing common pediatric arrhythmias, including supraventricular tachycardia (SVT) and ventricular tachycardia (VT).
- To highlight the considerations for antiarrhythmic drug selection in children, particularly those with underlying cardiac conditions.
Main Methods:
- Review of current diagnostic tools for pediatric arrhythmias, including ECG and ambulatory monitoring.
- Discussion of acute and long-term pharmacological and non-pharmacological treatment strategies for SVT and VT.
- Analysis of potential drug-related hazards in pediatric patients with structural heart disease or myocardial dysfunction.
Main Results:
- SVT is managed acutely with vagal maneuvers or AV conduction-slowing drugs, with long-term options including digoxin, verapamil, or propranolol.
- VT is treated acutely with DC cardioversion and lidocaine, with chronic management involving mexiletine, propranolol, or amiodarone.
- Children with congenital heart defects or myocardial dysfunction face increased risks from antiarrhythmic drugs, including cardiac function depression and proarrhythmia.
Conclusions:
- Effective antiarrhythmic therapy in children requires careful consideration of arrhythmia type, cardiac status, and potential drug side effects.
- Treatment strategies must be individualized to balance efficacy with the minimization of risks, especially in complex pediatric cardiac cases.
- Close monitoring for adverse events is essential throughout the course of antiarrhythmic treatment in pediatric patients.
Abstract:
Determining safe and effective antiarrhythmic therapy in paediatric patients requires definition of the mechanism of the arrhythmia, determination of associated risk factors for treatment (such as the presence of congenital cardiac defects, myocarditis or cardiomyopathy), and monitoring for potential drug side effects related to the treatment. A number of modalities for non-invasive evaluation of arrhythmias is available, including ECG, 24-hour ambulatory Holter monitoring, and transtelephonic ECG transmission. Arrhythmias requiring medical treatment in children with normal cardiac anatomy and function include supraventricular tachycardia (SVT), ventricular tachycardia (VT) and primary atrial tachycardias. SVT is treated acutely with vagal manoeuvres or drugs which slow AV conduction [adenosine (adenine riboside), edrophonium, phenylephrine or verapamil]. When medical conversion is not achieved, transoesophageal overdrive pacing or direct current (DC) cardioversion may be required. Long term drug therapy for SVT includes first-line treatment with digoxin, verapamil or propranolol. Ventricular tachycardia is managed acutely with DC cardioversion and intravenous lidocaine (lignocaine). Chronic drug regimens include mexiletine, propranolol or amiodarone. In children with structural congenital heart disease or myocardial dysfunction, hazards of drug therapy for arrhythmias include depression of cardiac function, proarrhythmia (drug-induced worsening of arrhythmias), and conduction abnormalities. Care must be taken to choose medication regimens which are likely to be effective with minimum risk of potentiating abnormal haemodynamics or conduction.
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
01:29Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:25Dysrhythmias VI: Management of Dysrhythmias
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias